Literature DB >> 28983000

Draft Genome Sequence Analysis of Multidrug-Resistant Escherichia coli Strains Isolated in 2013 from Humans and Chickens in Nigeria.

Poonam Sharma1, Sushim K Gupta1, Eyitayo O Adenipekun2, John B Barrett1, Lari M Hiott1, Tiffanie A Woodley1, Bamidele A Iwalokun3,4, Kolawole S Oyedeji2, Afolabi Oluwadun3, Hazem Ramadan5, Jonathan G Frye1, Charlene R Jackson6.   

Abstract

Here, we present the draft genome sequences of nine multidrug-resistant Escherichia coli strains isolated from humans (n = 6) and chicken carcasses (n = 3) from Lagos, Nigeria, in 2013. Multiple extended-spectrum β-lactamase (ESBL) genes were identified in these isolates.

Entities:  

Year:  2017        PMID: 28983000      PMCID: PMC5629057          DOI: 10.1128/genomeA.01073-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The use and misuse of antimicrobials around the world has led to the selection of various multidrug-resistant (MDR) bacteria in humans and animals. In humans, the spread of multidrug-resistant bacteria has increased considerably in hospitals and the community (1, 2). In livestock feeds, antimicrobials have been used to promote growth, as therapeutic agents, and as prophylactics, which has led to the exertion of selective pressure for the emergence of MDR bacteria causing foodborne infections in humans (3–7). Escherichia coli is a common commensal of the intestinal tract of humans and animals. It is also an opportunist pathogen manifesting in different disease conditions (8–11) and has been associated with illnesses caused by food-producing animals (4). The spread and emergence of MDR E. coli have been documented worldwide and thus are a major concern (12). In Nigeria, reports state that infections caused by E. coli are increasing (13, 14). In order to effectively treat these infections, it is important to understand the mechanisms of resistance in E. coli. As a first step in this study, we report here the draft genome sequences of nine MDR E. coli strains isolated from outpatients (n = 5), animal handlers (n = 1), and chickens (n = 3) in Lagos, Nigeria, in 2013 (15, 16). Genomic DNA from E. coli was extracted using the blood and tissue genomic DNA extraction kit (Qiagen, Germantown, MD). Extracted DNA was quantified using the Qubit double-stranded DNA (dsDNA) high-sensitivity (HS) assay kit, according to the manufacturer’s instructions (Life Technologies, Inc., Waltham, MA). The Illumina libraries were prepared using the Nextera XT DNA library preparation kit and Nextera XT index primers (Illumina, San Diego, CA). The library fragment size distribution was checked using the Bioanalyzer 2100 using Agilent high-sensitivity DNA kit (Agilent Technologies, Santa Clara, CA) and quantified using the Qubit DNA HS assay kit in a Qubit fluorometer (Thermo Fisher Scientific, USA). The generated libraries were then sequenced using MiSeq reagent kit version 3 with 600 cycles and a paired-end read length of 2 × 300 bp on an Illumina MiSeq platform. The quality metrics of the reads were determined by FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). The sequence data were assembled using the A5-miseq assembler (17), and the genome sequence was annotated via the NCBI Prokaryotic Genome Annotation Pipeline (18). The contigs were reordered with r2cat (19). The genome statistics are shown in Table 1.
TABLE 1 

Genome assembly statistics for Escherichia coli strains

IsolateSequence type (15)Isolation sourceGenome size (Mb)N50 (bp)No. of contigsGC content (%)No. of tRNAsTotal no. of genesAccession no.
38.ii.h131Human5,300,508200,21513450.81815,683NJAF00000000
129.h617Human4,864,884126,49217950.57805,224NJAE00000000
204ii.h542Human4,748,637102,76712750.85805,110NJAD00000000
299.h398Human5,107,66795,06416150.55805,535NJAC00000000
322i.h4143Human4,920,104166,9627950.78815,165NJAB00000000
382.h398Human5,108,22497,66516450.55795,545NJAA00000000
104162Chicken4,921,291193,7707850.78825,166NIZZ00000000
131i162Chicken4,965,831185,4739150.80825,237NIZY00000000
141131Chicken5,305,541230,02613050.80825,694NIZX00000000
Genome assembly statistics for Escherichia coli strains Antibiotic resistance genes were identified using ARG-ANNOT (20). All isolates had at least one extended-spectrum β-lactamase (ESBL) resistance gene detected. The isolates also harbored genes conferring resistance to aminoglycosides, tetracycline, trimethoprim, sulfonamides, fluoroquinolones, and chloramphenicol, consistent with their reported phenotypes (15, 16). The detection of circulating antibiotic resistance genes in bacteria from humans and food animals using genome sequencing is useful in predicting emerging resistance, especially in underfunded countries.

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under BioProject number PRJNA389301, and the accession numbers are listed in Table 1. The versions described in this paper are the first versions.
  19 in total

1.  A5-miseq: an updated pipeline to assemble microbial genomes from Illumina MiSeq data.

Authors:  David Coil; Guillaume Jospin; Aaron E Darling
Journal:  Bioinformatics       Date:  2014-10-22       Impact factor: 6.937

Review 2.  Food animals and antimicrobials: impacts on human health.

Authors:  Bonnie M Marshall; Stuart B Levy
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Prevalence and Antimicrobial Resistance in Escherichia coli from Food Animals in Lagos, Nigeria.

Authors:  Eyitayo O Adenipekun; Charlene R Jackson; Afolabi Oluwadun; Bamidele A Iwalokun; Jonathan G Frye; John B Barrett; Lari M Hiott; Tiffanie A Woodley
Journal:  Microb Drug Resist       Date:  2015-02-06       Impact factor: 3.431

Review 4.  Human health hazards from antimicrobial-resistant Escherichia coli of animal origin.

Authors:  Anette M Hammerum; Ole E Heuer
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

5.  Prevalence and multidrug resistance of Escherichia coli from community-acquired infections in Lagos, Nigeria.

Authors:  Eyitayo O Adenipekun; Charlene R Jackson; Hazem Ramadan; Bamidele A Iwalokun; Kolawole S Oyedeji; Jonathan G Frye; John B Barrett; Lari M Hiott; Tiffanie A Woodley; Afolabi Oluwadun
Journal:  J Infect Dev Ctries       Date:  2016-09-30       Impact factor: 0.968

Review 6.  Incidence of bloodstream infection: a review of population-based studies.

Authors:  K B Laupland
Journal:  Clin Microbiol Infect       Date:  2013-02-11       Impact factor: 8.067

Review 7.  Multidrug resistant commensal Escherichia coli in animals and its impact for public health.

Authors:  Ama Szmolka; Béla Nagy
Journal:  Front Microbiol       Date:  2013-09-03       Impact factor: 5.640

8.  r2cat: synteny plots and comparative assembly.

Authors:  Peter Husemann; Jens Stoye
Journal:  Bioinformatics       Date:  2009-12-16       Impact factor: 6.937

9.  Global dissemination of a multidrug resistant Escherichia coli clone.

Authors:  Nicola K Petty; Nouri L Ben Zakour; Mitchell Stanton-Cook; Elizabeth Skippington; Makrina Totsika; Brian M Forde; Minh-Duy Phan; Danilo Gomes Moriel; Kate M Peters; Mark Davies; Benjamin A Rogers; Gordon Dougan; Jesús Rodriguez-Baño; Alvaro Pascual; Johann D D Pitout; Mathew Upton; David L Paterson; Timothy R Walsh; Mark A Schembri; Scott A Beatson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

Review 10.  O157:H7 and O104:H4 Vero/Shiga toxin-producing Escherichia coli outbreaks: respective role of cattle and humans.

Authors:  Denis Piérard; Henri De Greve; Freddy Haesebrouck; Jacques Mainil
Journal:  Vet Res       Date:  2012-02-13       Impact factor: 3.683

View more
  2 in total

1.  Genetic Characterization of Antibiotic Resistant Enterobacteriaceae Isolates From Bovine Animals and the Environment in Nigeria.

Authors:  Christiana Jesumirhewe; Burkhard Springer; Franz Allerberger; Werner Ruppitsch
Journal:  Front Microbiol       Date:  2022-02-25       Impact factor: 5.640

2.  Whole genome sequencing of extended-spectrum β-lactamase genes in Enterobacteriaceae isolates from Nigeria.

Authors:  Christiana Jesumirhewe; Burkhard Springer; Franz Allerberger; Werner Ruppitsch
Journal:  PLoS One       Date:  2020-04-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.